Exagen Inc. beat EPS estimates 94% of the time across 16 reported quarters (15 beats, 1 misses), averaging +20.7% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $-0.19 | $-0.13 | +31.6% | Beat | Q2 FY26 call |
| Q1 FY26 | $-0.24 | $-0.17 | +29.2% | Beat | Q1 FY26 call |
| Q4 FY25 | $-0.20 | $-0.20 | +0.0% | Beat | |
| Q3 FY25 | $-0.13 | $-0.19 | -46.1% | Miss | |
| Q2 FY25 | $-0.18 | $-0.18 | +0.0% | Beat | Q2 FY25 call |
| Q1 FY25 | $-0.20 | $-0.20 | +0.0% | Beat | |
| Q4 FY24 | $-0.27 | $-0.20 | +25.9% | Beat | |
| Q3 FY24 | $-0.30 | $-0.28 | +6.7% | Beat | |
| Q2 FY24 | $-0.36 | $-0.16 | +55.6% | Beat | |
| Q1 FY24 | $-0.40 | $-0.19 | +52.5% | Beat | |
| Q4 FY23 | $-0.41 | $-0.31 | +24.4% | Beat | |
| Q3 FY23 | $-0.50 | $-0.31 | +38.0% | Beat |
Back to XGN overview · XGN holders · XGN KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.